OrbiMed's book
88 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| InSilico Medicine Cayman (HKG: 03696) | Biotech | $1.7B | — | — | |
| Treeline Biosciences | — | $1.3B | — | — | |
| Mirador Therapeutics | — | $1.0B | — | — | |
| Genfleet (HKG: 02595) | — | $799.7M | — | — | |
| Delfi Diagnostics | — | $725.0M | — | — | |
| ReCode Therapeutics | — | $700.0M | — | — | |
| Merlyn Mind | — | $668.0M | — | — | |
| Candid Therapeutics | Drug Discovery | $657.0M | — | — | |
| Kartos Therapeutics | — | $650.0M | — | — | |
| Iambic | — | $648.0M | — | — | |
| + 78 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 88 recorded positions
- ·Watchlist + alerts for OrbiMed's activity
Create free account
No card required